![]() Very common (10% or more): Diarrhea (up to 11.7%) Postmarketing reports: Pain in extremity (arm) Gastrointestinal Uncommon (0.1% to 1%): Malaise, asthenia Musculoskeletal Very common (10% or more): Fatigue (49.4 to 77.5%), use of antipyretic or pain medication (27.8% to 45.2%), fever of 38C or higher (4.1% to 24.3%) Postmarketing reports: Dizziness, syncope Other Currently available information is insufficient to determine a causal relationship with the vaccine. Onset of facial paralysis occurred on day 37 after dose 1 (patient only received one dose), and days 3, 9, and 48 after dose 2 in the treatment group onset of facial paralysis was day 30 and 102 in the placebo group. Very common (10% or more): Pain at injection site (78.3% to 90.5%), injection site swelling (up to 10.5%)Ĭommon (1% to 10%): Swelling, injection site redness/redness Nervous systemīell's palsy occurred in 4 patients in the treatment group versus 2 patients in the placebo group. Pain, redness, or swelling at the injection siteĪpplies to sars-cov-2 mrna (tozinameran) vaccine: intramuscular suspension.Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.Ĭheck with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them: More common These side effects may go away during treatment as your body adjusts to the medicine. Some side effects of sars-cov-2 mrna (tozinameran) vaccine may occur that usually do not need medical attention. puffiness or swelling of the eyelids or around the eyes, face, lips, or tongue. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |